Guardion Health Sciences Announces Cash Distribution to Shareholders
Guardion Health Sciences, Inc. recently informed its shareholders that a cash distribution of $3.25 per share of common stock will be made. This decision was reached by the Company's Board of Directors, representing a significant step in the company’s ongoing processes.
Details of the Cash Distribution
The declared amount of $3.25 will be distributed to those who held shares of the Company’s Common Stock on the designated record date. This record date was set for a recent day in October, marking a pivotal moment as it aligned with the Company's pre-announced legal dissolution.
Timing of the Distribution Payment
Stockholders can expect to receive their cash distribution by a specified date in late December. This timeline indicates the Company’s commitment to following through on its obligations to its shareholders amid the winding-down process.
Impact of Legal Dissolution
Prior to the effective date of this significant resolution, Guardion Health Sciences closed its stock transfer books, marking the cessation of any rights regarding shares, aside from the right to receive distributions based on the approved Plan of Liquidation and Dissolution.
Understanding the Liquidation Plan
As part of the liquidation, the Company has ceased all business operations, focusing solely on preserving the value of remaining assets. The process will involve a gradual settlement of obligations and the eventual distribution of assets to shareholders.
Legal Framework and Duration of the Process
Operating under the General Corporation Law of the State of Delaware, the Company will continue its existence for three years after the effective date. This extension is intended for the purpose of handling any lawsuit matters and facilitating the orderly closing of business affairs.
Future Expectations Following Legal Dissolution
The future of Guardion remains focused on ensuring compliance with legal obligations and fulfilling its commitments to shareholders. This will involve a careful and thoughtful approach to asset management during the dissolution process.
Analyzing Forward-Looking Statements
While discussing financial intentions, it is essential to understand that there are inherent uncertainties involved. The Company has made it clear that the projections shared about cash distributions rely on management’s expectations, which are subject to change based on various factors outside the Company’s control.
Cautions Regarding Financial Projections
As shareholders and stakeholders review these projections, they are reminded to consider the risks involved and not place undue reliance on these forward-looking statements. The Company’s ability to provide these distributions is tied to many unpredictable elements.
Contact Information for Shareholders
For shareholders requiring more information regarding the cash distribution and the Company’s status, they are encouraged to reach out directly to Guardion Health Sciences. The Company has provided an email contact and a phone number for any inquiries, reflecting its commitment to transparency during this transition.
Frequently Asked Questions
What is the cash distribution amount declared by Guardion Health Sciences?
The declared cash distribution amount is $3.25 per share of common stock.
When can shareholders expect to receive the distribution?
The Company expects payments to be completed by a date in late December.
What happens to the company after the legal dissolution?
Following dissolution, the company will focus on winding down operations and distributing remaining assets to stockholders.
How can shareholders get in touch with Guardion Health Sciences?
Shareholders can contact the company via email at investors@guardionhealth.com or call 1-800 873-5141 Ext 208 for inquiries.
What legal framework is guiding the dissolution process?
The dissolution process is governed by the General Corporation Law of the State of Delaware.
